Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-01

FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for buspirone hydrochloride by Heritage Pharmaceuticals Inc. (d/b/a Avet Pharmaceuticals Inc.).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buspirone hydrochloride (buspirone hydrochloride)

Snippet

SUPPL AP for BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)